CVS Health announced plans to separate into two publicly traded companies: CVS Health and CVS Pharmacy.
RT’s Three Key Takeaways:
- Strategic Separation: CVS Health announced plans to separate into two publicly traded companies focused on retail pharmacy operations and healthcare solutions.
- Executive Appointments: David Joyner will serve as chairman and chief executive officer of the healthcare solutions business, while Prem Shah will become chief executive officer of CVS Pharmacy.
- Projected Timeline: The transaction is scheduled to close in the first half of 2028, pending approval by the CVS Health board of directors and regulatory filings.
CVS Health announced plans to separate into two independent, publicly traded entities following a strategic review by its board of directors, according to a company news release.
Under the proposal, one organization will operate as a healthcare solutions business, while the other will run retail pharmacy and community healthcare operations. The separation is intended to expand access, lower costs, and enhance care coordination across both operating models, according to the company.
Division of Healthcare Assets
The healthcare solutions business will retain the name CVS Health on an interim basis and include Aetna, CVS Caremark, CVS Specialty, Oak Street Health, and Signify Health, according to the news release. This entity will focus on value-based care, benefits delivery, and in-home health services.
The second business, named CVS Pharmacy, will comprise roughly 9,000 retail pharmacies, mail pharmacy services, MinuteClinic locations including virtual care, and the Health100 technology services segment, the company stated in the news release.
“Our history is defined by proactively evolving to stay ahead of what’s next in healthcare, and in today’s environment, that means delivering more affordability, greater access, and a simpler experience,” said David Joyner, chairman and chief executive officer of CVS Health, in a news release. “Over the last two years, we have made meaningful progress: we built a world-class leadership team, strengthened our financials, revitalized operations across the enterprise, and drove total shareholder return. From a position of strength, and a focus on the long term, we plan to create two focused companies to improve consumer engagement, affordability, and care coordination.”
Leadership and Operational Plans
Following the separation, Joyner will serve as chairman and chief executive officer of the healthcare solutions entity, while Prem Shah, group president of CVS Health, will step into the role of chief executive officer of CVS Pharmacy, according to the news release.
“Aetna, CVS Caremark and CVS Specialty, along with our value-based care and in-home health businesses, will advance together as a leading healthcare solutions provider, delivering differentiated, comprehensive benefits to clients, members and patients,” said Joyner, chairman and chief executive officer of CVS Health, in a news release. “CVS Pharmacy will build on its position as America’s leading retail pharmacy, serving as the front door to health and care in our country as the most frequently accessed consumer health touchpoint.”
The pharmacy company intends to leverage its network of nearly 30,000 pharmacists to expand community clinical services and develop partnerships with payers, manufacturers, and pharmacy benefit managers, according to the news release.
Transaction Overview
The split is structured to qualify as a tax-free transaction for US federal income tax purposes for CVS Health and its shareholders, according to the news release. Upon completion, current shareholders will receive equity in both publicly traded corporations.
The proposed separation is targeted for completion in the first half of 2028, subject to closing conditions, a Form 10 registration filing with the US Securities and Exchange Commission (SEC), and final sign-off from the CVS Health board of directors, according to the news release. Patient care, prescription dispensing, and member health plans will continue without interruption throughout the process, the company says.